Single Dose of Keytruda May Help Put Melanoma Into Remission

TUESDAY, Feb. 26, 2019 -- For people with the deadly skin cancer melanoma, one dose of the drug Keytruda before surgery might stop the cancer in its tracks, according to a groundbreaking new study.
Keytruda (pembrolizumab) is a PD-1 inhibitor, an...

Source: Drugs.com - Daily MedNews - February 26, 2019 Category: General Medicine Source Type: news